Winnipeg, Manitoba – Kane Biotech Inc. announces the approval of dermatological care products (known as DispersinB) for human consumption. Approval obtained from the Natural Health Products Directorate (NHPD) of Health Canada.
Overview of Kane Biotech Inc.
Primarily, Kane Biotech Inc. is a biotechnology company. It is engaged in developing and commercializing products that prevent and eradicate microbial biofilms. The company has recently obtained the approval of its dermatological care products for human use from Health Canada’s NHPD. The products include DispersinB cream and shampoo. NHPD has authorized the manufacturing and commercialization of such products in Canada. The organization has also approved the use of these products in clinical studies, or in an urgent care clinic for efficacy claims enhancement.
Characteristics of DispersinB
The characteristic of DispersinB has unique antibiofilm-antimicrobial formulation. This product is also antibiotic-free. DispersinB can be applied to the scalp, hair, and skin. The skin care cream can kill bacteria that are embedded in the pre-formed microbial biofilm. This causes recurring infections related to dermatitis, eczema, and chronic inflammatory conditions of the skin. Its biofilm formation is associated with anti-pruritic and anti-inflammatory effects. As an urgent care solution, the cream product can be used in relieving skin irritations, dryness, scaling, itching, redness, contact dermatitis, psoriasis, and others. Meanwhile the shampoo product is used in relieving itching and controlling flaking at the same time.
Animal Health Market
Currently, the company is focusing its resources towards the animal health sector, establishing these products and testing them in order to strengthen their value proposition. Aside from the approved dermatological care products for human use,other ongoing activities include market messaging, pricing models, and development of further applications. It has been successful in manufacturing products in multiple markets, and pursuing other opportunities. Some urgent care clinics may be distributing their products which include StrixNB powder and spray, DispersinB topical spray, and other products for animal health.
Human Health Market
Today, the company tends to distribute its resources in manufacturing products for the human health market as well. The company’s latest product’s approval for human use is a significant breakthrough. The DispersinB skin cream and shampoo will provide consumers with a sense of urgent care near me solution towards their dermatological needs. The company claims that they have evidence that their technologies have the ability to either destroy or prevent biofilms through medical and industrial applications. The development of the company’s dermatological care products for human use was brought about by their continuous biofilm claims.
